[HTML][HTML] Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
AstraZeneca-Sanger Drug … - Nature …, 2019 - yonsei.elsevierpure.com
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
MP Menden, D Wang, MJ Mason, B Szalai… - 2019 - notablesdelaciencia.conicet.gov.ar
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
MP Menden, D Wang, MJ Mason… - Nature …, 2019 - tobias-lib.ub.uni-tuebingen.de
Community assessment to advance computational prediction of cancer drug combinations in a
pharmacogenomic screen Community assessment to advance computational prediction of …
pharmacogenomic screen Community assessment to advance computational prediction of …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
MP Menden, D Wang, MJ Mason, B Szalai… - NATURE …, 2019 - real.mtak.hu
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
MP Menden, D Wang, MJ Mason… - Nature …, 2019 - econpapers.repec.org
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
AstraZeneca-Sanger Drug … - Nature …, 2019 - researchinformation.amsterdamumc …
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
MP Menden, D Wang, MJ Mason… - NATURE …, 2019 - scholar.korea.ac.kr
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
[PDF][PDF] Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
M Menden, D Wang, MJ Mason, B Szalai, KC Bulusu… - 2019 - repository.ubn.ru.nl
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
AstraZeneca-Sanger Drug Combination … - Nature …, 2019 - pure.korea.ac.kr
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop
resistance that might be overcome with drug combinations. However, the number of possible …
resistance that might be overcome with drug combinations. However, the number of possible …